Discontinued — last reported Q3 '24
Insmed Stock Issued During Period, Value, Stock Options Exercised decreased by 12.6% to $30.27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.9%, from $29.71M to $30.27M. Over 4 years (FY 2021 to FY 2025), Stock Issued During Period, Value, Stock Options Exercised shows an upward trend with a 57.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Reflects the scale of capital inflow from employee option activity and the corresponding increase in issued share capital.
The total monetary value of common stock issued during the period specifically related to the exercise of stock options....
Standard disclosure in the statement of stockholders' equity.
other_stock_issued_during_period_value_stock_options_exercised| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.51M | $5.51M | $5.51M | $4.88M | $4.88M | $4.88M | $4.88M | $1.14M | $7.28M | $2.26M | $7.72M | $4.05M | $68.57M | $26.88M | $13.74M | $29.71M | $36.97M | $34.41M | $34.62M | $30.27M |
| QoQ Change | — | +0.0% | +0.0% | -11.5% | +0.0% | +0.0% | +0.0% | -76.6% | +539.4% | -69.0% | +241.9% | -47.5% | >999% | -60.8% | -48.9% | +116.2% | +24.4% | -6.9% | +0.6% | -12.6% |
| YoY Change | — | — | — | — | -11.5% | -11.5% | -11.5% | -76.6% | +49.4% | -53.7% | +58.3% | +255.8% | +841.5% | >999% | +78.0% | +633.2% | -46.1% | +28.0% | +152.0% | +1.9% |